Skip to content

Vaccines alone aren’t enough to combat AMR, claims new WHO report

By asianet

The Global Hygiene Council (GHC) calls for the use of hygiene practices, such as handwashing, alongside vaccinations to prevent the spread of infectious diseases and reduce the impact of antimicrobial resistance (AMR). A recent report [ https://www.who.int/publications/i/item/9789240052451 ] published by the World Health Organization (WHO) identified vaccines as “highly effective tools in combating AMR”. Despite … Continued

Karyopharm and Menarini Group Receive Full Marketing Authorisation from the European Commission for NEXPOVIO(R) (selinexor) for the Treatment of Patients with Multiple Myeloma After at Least One Prior Therapy

By asianet

– Based on Results from Phase 3 BOSTON Study, Marketing Authorisation Expands Multiple Myeloma Indication – – Approval Follows Positive Opinion by European Committee for Medicinal Products for Human Use (CHMP) in May 2022 – Karyopharm Therapeutics Inc. (Nasdaq: KPTI), a commercial-stage pharmaceutical company pioneering novel cancer therapies, and the Menarini Group (“Menarini”), a privately-held, … Continued

llumina Among First in the World to Receive Approval of Science-Based Net-Zero Target

By asianet

The Science Based Targets initiative has validated Illumina’s targets to reach Net-Zero greenhouse gas emissions by 2050 Illumina, Inc. (NASDAQ: ILMN), a global leader in DNA sequencing and array-based technologies, announced today it is among the first group of companies worldwide to receive approval of its net-zero targets by the Science Based Targets initiative (SBTi). … Continued

DarwinHealth Publishes Results of Novel, Viral Checkpoint-based Technology for Predicting Drugs that Inhibit SARS-CoV-2 Replication: Global Collaboration Highlights Generalizability of Reported ViroTreat Model for Host Cell-Directed Antiviral Drug Discovery, the Role of Master Regulator Proteins, and Application to other Viral Pathogens and Pandemic Response

By asianet

DarwinHealth, Inc., a New York-based biotechnology and cancer drug discovery company announces the July 19, 2022 online publication in Communications Biology (a Nature Portfolio peer-reviewed journal) of a foundational paper focused on new approaches to antiviral drug discovery, “A model for network-based identification and pharmacological targeting of aberrant, replication-permissive transcriptional programs induced by viral infection.” … Continued

SHL Medical announces plans for a new manufacturing site in the US

By asianet

SHL Medical (hereinafter referred to as “SHL”) has revealed plans for a new manufacturing site in the US, in response to the growing market demand for its autoinjector product portfolio. The decision stems from SHL’s strategic assessments in extending its production to North America. Photo – https://mma.prnewswire.com/media/1858961/SHL_Medical_SC.jpg The new US site will be located in … Continued

Zymo Research’s DNA/RNA Shield(TM) Inactivates Monkeypox for the Collection and Transportation of Samples

By asianet

Zymo Research Corp., in collaboration with the Institute of Virology, University Medical Center Freiburg, Germany, demonstrated data showing their DNA/RNA Shield(TM) Inactivating Transport Medium (ITM) completely inactivated recent Monkeypox virus isolates. Photo – https://mma.prnewswire.com/media/1859786/Zymo_Research_Corp_ITM.jpg Photo – https://mma.prnewswire.com/media/1859787/Zymo_Research_Corp_Assay.jpg This data comes at a critical time as Monkeypox cases continue to climb worldwide and scientists are seeking … Continued

Nefertiti Greene Joins Mars Petcare to Run New Science & Diagnostics Division

By asianet

– Mars Petcare announces former Johnson & Johnson executive Nefertiti Greene as member of Global Petcare Leadership team – Greene will head new division within Mars Petcare, Science & Diagnostics – Demonstrates company’s deep commitment to advancing science and innovation Today, Mars Petcare [https://www.mars.com/made-by-mars/petcare], the leading pet health, services, and nutrition company, has named Nefertiti … Continued

Oncoshot Receives Funding To Expand Cancer Data Sharing Capabilities For Hospitals and Industry

By asianet

Oncoshot today announced a pre-series A funding round led by MassMutual Ventures (MMV). Other investors for this stage come from a suite of healthtech veterans that include Milltrust International and health industry angel investors. This funding will support Oncoshot’s further expansion into Australia and India where, including its home country Singapore, it is already in … Continued

LIMACORPORATE AND ORTHOFIX MEDICAL ANNOUNCE PARTNERSHIP TO PROVIDE SOLUTION FOR PATIENTS WITH HIGH HIP DISLOCATION FOR THE US MARKET

By asianet

Limacorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, and Orthofix Medical Inc, a global medical device company with a spine and orthopedics focus, today announced a licensing partnership for the U.S. market to provide a novel solution for patients with the challenging condition of chronic high dislocation of the hip. … Continued